Related Experiment Video

Updated: Dec 28, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.0K

Management of Infants with Congenital Adrenal Hyperplasia

Aashima Dabas1, Pallavi Vats1, Rajni Sharma2

  • 1Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.

Indian Pediatrics
|February 16, 2020
PubMed

Insights

Lifelong glucocorticoid replacement and regular follow-up are crucial for managing congenital adrenal hyperplasia (CAH) in infants. This review details follow-up strategies for classical CAH in India, emphasizing early hydrocortisone and fludrocortisone treatment.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Congenital adrenal hyperplasia (CAH) necessitates lifelong glucocorticoid therapy and monitoring for complications.
  • Classical CAH requires prompt management from the newborn period through childhood.

Purpose of the Study:

  • To review the follow-up and management guidelines for infants with classical CAH within the Indian context.
  • To provide evidence-based recommendations for treatment initiation and complication monitoring.

Main Methods:

  • Literature review focusing on classical CAH management in infants.
  • Analysis of current treatment protocols and recommendations relevant to India.

Main Results:

  • Early initiation of oral hydrocortisone in divided doses is recommended post-diagnosis.
  • Fludrocortisone is advised for all infants diagnosed with classical CAH.
  • Routine monitoring for disease and treatment-related complications is essential.

Conclusions:

  • Standardized follow-up protocols are vital for managing infants with classical CAH.
  • The use of prenatal steroids for preventing fetal virilization remains a controversial topic.
  • Adherence to recommended treatment regimens ensures better patient outcomes.

More Related Videos

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.4K
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.2K

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
4.3K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
394
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
159
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
234
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146